Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurologic Manifestations 1Brain Neoplasms 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Pliability × Clear all
NCT04485767 2024-08-20

RESIST-ADT (Androgen Deprivation Therapy)

Dana-Farber Cancer Institute

Phase NA Completed
21 enrolled
Genitourinary

Prostatic Neoplasms

NCT05531695 2022-09-08

ESIBAC

Hull University Teaching Hospitals NHS Trust

Phase NA Completed
10 enrolled
CNS

Brain Neoplasms, Neurologic Manifestations

NCT00766311 2012-01-09

XRCISL

St. Jude Children's Research Hospital

Phase NA Completed
20 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡